CNBX Pharmaceuticals Inc.
CNBX· OTC
CNBXCNBX Pharmaceuticals Inc.
Filed Nov 30, 2022 · 10-K · 91 days after period end · 0001683168-22-008095
derived · Computed from the longer spans the company filed.
| Metric | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures | Q4 2019dderived from reported figures |
|---|---|---|---|---|
| Revenue | — | $0.00 | $2.21K | $2.06K |
| Net Income | -$479.71K | -$681.15K | -$731.73K | -$1.39M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
CNBX Pharmaceuticals Inc. · CIK 1343009 · Engraved from SEC EDGAR
ended Aug 31, 2022 · filed Nov 30, 2022 · 91 d after period end
